TrialEuropean urology2021

Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial.

Thomas Powles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.